GoHealthcare MSK Specialty Procedure Library™ | Lumbar Fusion Procedures

Oblique Lateral Interbody Fusion (OLIF / ATP)

Developed by Pinky Maniri, Founder & Chief Executive Officer, GoHealthcare Practice Solutions

Clinical, coverage, medical necessity, prior authorization, documentation, coding, reimbursement, denial prevention, and operational guidance for MSK specialty teams.

This evergreen operational reference is designed for physicians, APPs, prior authorization teams, utilization management nurses, practice administrators, revenue cycle professionals, ASCs, hospitals, and healthcare executives. Verify current patient-specific payer, coding, clinical, and site-of-service requirements before use.

Request HelpView Case StudiesProcedure Library

Up to 98%

Company-reported prior authorization approval performance in managed workflows. Results vary by payer, procedure, documentation quality, benefit design, and client implementation.

On This Page

Procedure Guide Navigation

Use the links below to move directly to the clinical, payer, coding, documentation, denial-prevention, and operational sections.

Evidence at a GlanceProcedure OverviewRelevant Anatomy (High-Level)Clinical IndicationsPatient SelectionContraindicationsConservative Treatment RequirementsImaging RequirementsMedical NecessityDocumentation RequirementsDevice Manufacturers & System ConsiderationsCMS / Medicare CoverageCommercial Payer ComparisonPrior Authorization WorkflowCommon Prior Authorization DenialsAppeal StrategiesCoding & Billing OverviewApplicable CPT CodesHCPCS Codes (When Applicable)Common ICD-10-CM Diagnosis CodesApplicable ModifiersClinical Documentation ChecklistProcedure Comparison (When Applicable)GoHealthcare Clinical InsightsGoHealthcare Leadership PerspectiveGoHealthcare Prior Authorization InsightGoHealthcare Case StudyGoHealthcare Best PracticesCommon MistakesPearls and PitfallsFrequently Asked QuestionsKey TakeawaysFuture OutlookReferences

01

Coverage, Documentation & Operations

Evidence at a Glance

Oblique lateral interbody fusion (OLIF), also called the anterior-to-psoas (ATP) approach, reaches the lumbar disc through an oblique retroperitoneal corridor that runs between the anterior border of the psoas muscle and the great vessels. By working in front of the psoas rather than through it, OLIF avoids the transpsoas dissection of the lateral (XLIF) approach and the direct great-vessel mobilization of the anterior (ALIF) approach. It restores disc height and lordosis, provides indirect decompression, and - via the OLIF51 variant - can address L5-S1, which the transpsoas approach cannot.

Domain	Summary (verify against current payer policy & date of service)
Primary CPT®	22558 (anterior/anterolateral interbody arthrodesis, single interspace, lumbar); +22585 each additional interspace. There is no distinct oblique code.
Coding caution	OLIF (anterolateral, retroperitoneal) uses 22558. Do not confuse it with OLLIF, a different posterior trans-Kambin technique for which 22558 is not appropriate.
Access range	The pre-psoas oblique corridor reaches L1/L2 to L5 (OLIF25) and, via a variant, L5-S1 (OLIF51) - so unlike the transpsoas lateral approach, OLIF can address L5-S1.
Corridor	Oblique retroperitoneal window between the anterior psoas and the great vessels; typically left-sided. OLIF51 works below the vascular bifurcation (ALIF-like) and often uses an access surgeon.
Neuromonitoring	Less central than in the transpsoas approach because the psoas is not traversed; when a dedicated monitoring professional is used, +95940 / +95941 / G0453 apply (bundled if performed by the surgeon).
Medicare NCD / LCD	No NCD specific to lumbar fusion. MAC LCDs (e.g., L37848; historical L33382) require documented spondylolisthesis and/or instability; fusion for isolated DDD is generally non-covered.
2026 site-of-service	As part of the CY2026 IPO-list phase-out (musculoskeletal-first), 22558 was among the fusion codes CMS identified for IPO removal / ASC-CPL addition. Confirm 22558's final OPPS Addendum B / ASC Addendum AA status at the date of service.
Conservative therapy	Typically 6 weeks to 6 months of documented, failed, structured non-operative care (oblique-device labels commonly specify at least 6 months).
Biologic note	rhBMP-2 (Infuse) is on-label only for single-level anterior ALIF; use in an oblique (OLIF/ATP) fusion is off-label and payer-restricted.
Typical approval driver	A clear, imaging-correlated instability, listhesis, or coronal/deformity-correction rationale tied to failed conservative care - not axial back pain alone.

Terminology. OLIF and ATP describe the same anterior-to-psoas oblique technique; OLIF25 denotes the L1/L2-L5 approach and OLIF51 the L5-S1 approach. Device names are used for identification only. How to use this guide. Every code and policy statement should be re-verified at the point of care.

02

Coverage, Documentation & Operations

Procedure Overview

OLIF/ATP approaches the disc from an anterior-oblique angle with the patient in the lateral decubitus position, usually from the left side to keep the aorta (rather than the thin-walled vena cava) in view and to let the peritoneal contents fall away with gravity. The surgeon works through the natural corridor between the anterior psoas and the great vessels - a window that averages roughly 18 mm from L2 to L5 and can be widened with gentle psoas retraction. After discectomy, a wide, lordotic interbody spacer is placed on the apophyseal ring, restoring disc height, indirectly decompressing the neural elements, and correcting coronal and sagittal alignment.

Two features distinguish OLIF operationally. First, because the corridor does not traverse the psoas, lumbar-plexus and psoas morbidity are lower than in the transpsoas approach, and intraoperative neuromonitoring is used more selectively; the trade-off is closer proximity to vascular and autonomic structures. Second, the oblique corridor reaches L5-S1 through a distinct variant (OLIF51) that works below the vascular bifurcation much like an anterior lumbar interbody fusion, so OLIF can build a construct from the upper lumbar spine to the sacrum - often in a single position that also permits posterior fixation. The technique was first described by Mayer in 1997 and refined by Silvestre and colleagues in 2012.

GOHEALTHCARE CLINICAL INSIGHTS - WHAT MAKES OLIF DIFFERENT

Relative to XLIF and ALIF, an OLIF record turns on three distinctions: (1) the corridor is pre-psoas and near the vessels and sympathetic chain, so the complication and consent profile differs from a transpsoas case; (2) the level reach includes L5-S1 (OLIF51), which is ALIF-like and often involves an access surgeon; and (3) neuromonitoring is selective rather than mandatory. Capturing these up front - especially the OLIF51 access-surgeon arrangement - prevents the most common OLIF-specific authorization and claim problems.

03

Coverage, Documentation & Operations

Relevant Anatomy (High-Level)

Only the anatomy needed to understand indications, documentation, coverage, and approach risk is summarized here; this guide is not a surgical atlas.

n Pre-psoas oblique corridor. The working window between the anterior border of the psoas and the great vessels; its width (averaging ~18 mm from L2 to L5) is a key selection variable. n Great vessels and bifurcation. The aorta and inferior vena cava and their iliac branches border the corridor; the aortic/caval bifurcation defines whether a level is approached above (OLIF25) or below (OLIF51) it. n Lumbar sympathetic chain. Runs along the anterolateral vertebral bodies within the corridor; injury can cause a relative sympathectomy (a warmer, sometimes discolored ipsilateral leg). n Ureter and retroperitoneal structures. The ureter and peritoneal contents must be protected during the retroperitoneal dissection. n Psoas and lumbar plexus. The plexus lies within the psoas; because OLIF stays anterior to the psoas, plexus and psoas morbidity are reduced relative to the transpsoas approach. n Superior hypogastric plexus (at L5-S1). Relevant to OLIF51, where injury can cause retrograde ejaculation in males - a consent point shared with ALIF.

04

Coverage, Documentation & Operations

Clinical Indications

OLIF/ATP is generally indicated when a structural, segmental problem produces concordant, disabling symptoms unresponsive to appropriate non-operative care, and where an oblique approach offers advantages in indirect decompression, alignment restoration, or multilevel access including L5-S1. Commonly accepted indications (mirroring oblique-device FDA labeling) include:

n Degenerative disc disease (discogenic back pain with radiographically confirmed degeneration) at one or two contiguous levels, with instability or as part of a reconstructive strategy. n Degenerative spondylolisthesis , typically up to Grade 1, with instability. n Degenerative scoliosis / coronal deformity , where the oblique approach enables multilevel coronal and sagittal correction, often from the upper lumbar spine to the sacrum. n Adjacent-segment disease above or below a prior fusion. n Spinal stenosis amenable to indirect decompression through disc-height restoration, in the setting of instability. n Symptomatic pseudarthrosis (failed prior fusion) at an accessible level. n L5-S1 pathology approachable through the OLIF51 variant when an anterior-column construct is desired.

WATCH-OUTS - INDICATION AND CORRIDOR LIMITS

Isolated axial back pain from degenerative disc disease without instability or a defined reconstructive goal remains payer-scrutinized. Upper lumbar levels (L1-2, L2-3) are more difficult because of the rib cage, pleura, and diaphragm. A narrow or vessel-crowded pre-psoas corridor - and, at L5-S1, an unfavorable iliac vein or iliolumbar vein - can make the oblique approach unsafe. Direct decompression for high-grade central stenosis or a sequestered fragment is not achieved by indirect decompression alone; document the strategy.

05

Coverage, Documentation & Operations

Patient Selection

Durable outcomes and clean authorizations depend on selecting patients whose pathology, symptoms, modifiable risk profile, and corridor and vascular anatomy align. Selection factors reviewers and surgeons weigh:

n A workable pre-psoas corridor on axial imaging (psoas-to-vessel window; vessel and sympathetic-chain position), particularly for L5-S1 (OLIF51), where the iliac and iliolumbar veins govern feasibility. n Target levels appropriate to the approach (well-established at L3-4 and L4-5; feasible from L1/L2 to S1 with planning). n Concordance between imaging, examination, and symptoms; a documented, failed, structured course of conservative care. n Indication suited to indirect decompression, or a documented plan for direct decompression where needed. n Absence of prohibitive prior retroperitoneal surgery / adhesions on the approach side. n Nicotine / tobacco status with cessation counseling; bone-density status (osteopenia/osteoporosis affects subsidence risk and fixation strategy). n Body mass index, diabetic control, and comorbidities; male patients counseled on retrograde-ejaculation risk when OLIF51 is planned.

06

Coverage, Documentation & Operations

Contraindications

Absolute / near-absolute

n Vascular anatomy precluding safe oblique access (great vessels or iliac/iliolumbar veins overlying the corridor; severe atherosclerotic disease). n Active local or systemic infection (unless fusion is being performed to treat spinal infection). n Prohibitive prior retroperitoneal surgery with dense adhesions. n Medical instability precluding a major spine operation.

Relative / conditional

n Narrow or crowded pre-psoas corridor at the target level. n Uncorrected severe osteoporosis (subsidence risk; address before or concurrently). n Active nicotine use (many policies and device labels require cessation/counseling). n Upper lumbar targets (L1-2, L2-3) with rib-cage/pleural/diaphragmatic constraints. n High-grade spondylolisthesis or pathology requiring direct decompression not achievable indirectly. n Absence of a structural target - pain without instability or a defined reconstructive goal.

07

Coverage, Documentation & Operations

Conservative Treatment Requirements

Payers - and oblique-device FDA labeling, which commonly specifies at least six months of non-operative treatment condition elective OLIF approval on documented, failed conservative care. The record should show structured care that was actually trialed:

n Activity modification and a supervised or prescribed physical therapy program, with dates, duration, and response. n Pharmacologic management appropriate to the diagnosis, with response documented. n Interventional procedures where clinically appropriate (for example, epidural steroid injection), with dates and outcomes. n Home exercise, bracing, or activity-based programs where relevant. n A clear statement that symptoms and functional impairment persisted despite the above.

GOHEALTHCARE PRIOR AUTHORIZATION INSIGHT - MAKE CONSERVATIVE CARE AUDIT-PROOF

The most avoidable fusion denial is a conservative-care timeline a reviewer cannot reconstruct. Capture the modality, the start and end dates, the provider, and the measured response for each trial. As with the other interbody techniques, aligning the documented conservative-care duration to the six-month threshold common in oblique-device labeling satisfies both the payer criterion and the device label in one step.

08

Coverage, Documentation & Operations

Imaging Requirements

Imaging must establish the structural diagnosis, the dynamic component where instability is claimed, and - uniquely for OLIF - the pre-psoas corridor and vascular anatomy. Expect payers and surgeons to require:

n MRI of the lumbar spine (or CT / CT-myelogram when MRI is contraindicated) demonstrating level-concordant pathology. n Axial assessment of the pre-psoas corridor (psoas-to-vessel window, sympathetic-chain and vessel position), and at L5-S1 the iliac/iliolumbar venous anatomy for OLIF51 feasibility. n Weight-bearing flexion / extension radiographs when instability or spondylolisthesis is the indication. n Standing / coronal (scoliosis) and sagittal-alignment films where deformity or coronal correction is part of the rationale. n A radiology report and, ideally, the treating surgeon's correlation of imaging to symptoms, exam, and the chosen oblique approach.

WATCH-OUTS - IMAGING PITFALLS THAT TRIGGER DENIALS

Submitting only supine MRI for an instability-based request is a common miss. For OLIF, confirm the pre-psoas corridor is workable and, for L5-S1, that the venous anatomy supports OLIF51 - supine imaging can misrepresent the corridor that will be present in the lateral decubitus position. Indirect decompression must be justified by imaging showing recoverable disc/foraminal height.

09

Coverage, Documentation & Operations

Medical Necessity

Medical necessity for OLIF is built, not asserted. The record should demonstrate a logical chain from structural pathology to disabling, concordant symptoms, through failed conservative care, to a fusion whose specific goal (stabilization, indirect decompression, coronal/deformity correction, or anterior-column support at L5-S1) is stated, at a level the oblique corridor can reach. Elements reviewers weigh most heavily:

n A specific structural diagnosis with level(s) and, for listhesis, grade; for deformity, the coronal/sagittal parameters. n Concordant symptoms and objective examination findings. n Imaging that corroborates the diagnosis at the level to be fused and confirms corridor feasibility.

n A documented, dated, failed course of appropriate conservative care (commonly six months for oblique-device indications). n A rationale for the oblique approach specifically (indirect decompression, alignment, multilevel/L5-S1 access), and a decompression plan where indirect decompression is insufficient. n An explicit medical-necessity statement authored by the operating surgeon.

GOHEALTHCARE LEADERSHIP PERSPECTIVE - SAME PIVOT, DIFFERENT CORRIDOR

Every lumbar fusion coverage decision turns on the same pivot: instability (or a defined reconstructive goal), not stenosis or axial pain alone - the lesson of SLIP tempered by the decompression-alone non-inferiority signal in Forsth and NORDSTEN-DS. OLIF does not change that pivot; it changes the corridor and adds two documentation obligations. First, because decompression is usually indirect, the surgeon must state how disc-height restoration will decompress the symptomatic level. Second, when L5-S1 is addressed through OLIF51, the record should reflect the ALIF-like nature of that exposure and any access-surgeon involvement. Practices that document the corridor rationale and the L5-S1 arrangement, not just the diagnosis, see fewer pends and cleaner claims.

10

Coverage, Documentation & Operations

Documentation Requirements

Use the following as a pre-submission checklist. Each item that is present, dated, and specific reduces the probability of a request for information, a peer-to-peer, or a denial.

n Chief complaint and symptom duration, with functional impact (e.g., ODI or documented activity limitation) n Pain characterization and distribution (axial vs. radicular vs. claudicant) n Focused neurological examination (motor, sensory, reflexes, provocative signs) n Specific structural diagnosis with level(s); for listhesis, grade; for deformity, coronal/sagittal parameters n MRI or CT correlated to the symptomatic level, plus axial pre-psoas corridor / vascular assessment n For L5-S1 (OLIF51), documentation of iliac/iliolumbar venous anatomy and corridor feasibility n Weight-bearing flexion/extension radiographs when instability is the indication; coronal/alignment films for deformity n Itemized, dated conservative-care ledger with measured response (commonly six months) n Explicit indirect-decompression rationale, or a documented plan for direct decompression n Access-surgeon arrangement documented where OLIF51 is planned (for co-surgery reporting) n Nicotine/tobacco status and cessation counseling; bone-density status (subsidence risk) n Planned levels; standalone vs. lateral-plate vs. supplemental posterior fixation; interbody device; graft/biologic n Explicit surgeon medical-necessity statement and site-of-service rationale

11

Coverage, Documentation & Operations

Device Manufacturers & System Considerations

OLIF is device-intensive; the guide addresses the oblique implant landscape at an operational level. Mention of specific manufacturers is for identification only and is not an endorsement.

Oblique interbody spacers & systems

Category	Representative systems / notes
Anterior/oblique lumbar fusion systems	Purpose-built OLIF25 (L2-L5) and OLIF51 (L5-S1) platforms (e.g., Medtronic Divergence-L Anterior/Oblique Lumbar Fusion System and associated cages), with lateral-decubitus retractors and navigation-compatible instruments (OLIF360 with navigation/imaging).
PEEK / titanium / porous Ti oblique cages	Wide, lordotic footprints seated on the apophyseal ring; porous/3D-printed titanium adds osteoconductive surface; radiodense implants may obscure intra-cage fusion assessment.

Category	Representative systems / notes
Anterior/oblique plates & integral fixation	Low-profile plates or integrated screws for stand-alone or supplemental fixation; device labels may require anterior fixation for high-lordosis cages.

Fixation strategy & labeling

n OLIF may be performed stand-alone, with an anterior/oblique plate, or supplemented with posterior pedicle-screw fixation (often in the same lateral position). Posterior fixation is reported with the posterior instrumentation codes; an anterior/oblique plate with the anterior instrumentation codes. n Representative labeling (e.g., an anterior/oblique lumbar fusion system) covers DDD at one or two contiguous levels from L2 to S1 , with or without up to Grade 1 spondylolisthesis or retrolisthesis, used with autograft and supplemental fixation; high-lordosis cages may require at least anterior fixation.

Biologics, FDA labeling & MRI conditionality

n Allograft, autograft, demineralized bone matrix, ceramics, and cellular bone matrices fill the oblique cage. n rhBMP-2 (Infuse) is off-label for OLIF - its FDA approval is limited to single-level anterior ALIF with a specified cage. Off-label oblique use is payer-restricted; document rationale and consent if used. n Most contemporary titanium and PEEK constructs are labeled MR Conditional ; the specific conditions live in the manufacturer's IFU. Confirm the device's coverage status and on-label level/indication, not just its clearance.

GOHEALTHCARE CLINICAL INSIGHTS - OLIF51 IS AN ALIF IN DISGUISE

Operationally, the OLIF51 (L5-S1) portion behaves like a laterally-positioned ALIF: it works below the vascular bifurcation, benefits from access-surgeon experience, and carries the anterior-column risk profile (vascular injury, retrograde ejaculation). Plan its coding and consent accordingly - including a potential co-surgeon arrangement rather than treating a combined OLIF25+OLIF51 construct as a single uniform lateral case.

Strengthen Authorization and Revenue Integrity

GoHealthcare helps MSK specialty organizations align documentation, payer criteria, coding, scheduling, and denial-prevention workflows.

Request HelpView Case Studies

12

Policy, Evidence & Source Guidance

CMS / Medicare Coverage

There is no National Coverage Determination specific to lumbar interbody fusion. Coverage is shaped by (1) MAC LCDs and articles, (2) the OPPS/ASC payment framework and the Inpatient-Only transition, and (3) the 2-midnight rule. Because OLIF is reported with the anterior/anterolateral arthrodesis code 22558, the same CMS considerations that apply to anterior lumbar fusion apply here. Key points for 2026:

n LCDs. Several MACs maintain lumbar-fusion LCDs (for example, L37848 Lumbar Fusion; the earlier L33382). These generally cover fusion for documented spondylolisthesis or instability and treat fusion for isolated degenerative disc disease as not medically necessary; investigational devices/techniques are commonly excluded. n Inpatient-Only phase-out. In the CY2026 OPPS/ASC Final Rule, CMS finalized eliminating the IPO list over a three-year transition beginning with musculoskeletal procedures - removing roughly 285 codes and adding hundreds of codes to the ASC Covered Procedures List. 22558 (which reports OLIF) was among the anterior fusion codes CMS identified for this move; published summaries most often cite the posterior codes (22630/22633) as spine examples. Confirm 22558's final status directly in OPPS Addendum B and ASC Addendum AA at the date of service. n Neuromonitoring, when used. IONM has its own MAC coverage articles (e.g., billing/coding article A56722); when separately reported it must meet the dedicated-professional and time requirements. It is a distinct coverage stream and, for OLIF, is used more selectively than in a transpsoas case. n Site of service is a clinical decision. Removal from the IPO list does not require outpatient performance; the surgeon documents why inpatient, HOPD, or ASC is appropriate, and the setting must support the approach (and, for OLIF51, access-surgeon logistics). n 2-midnight rule. When inpatient admission is planned, the record must support an expected stay crossing two midnights or otherwise justify inpatient status.

WATCH-OUTS - THE 2026 SITE-OF-SERVICE TRAP

The IPO change is an opportunity and a liability. Commercial and Medicare Advantage plans may now steer oblique fusion to lower-cost sites and deny inpatient stays that are not clearly justified. An ASC performing a newly eligible oblique fusion must confirm device-intensive payment, access-surgeon and vascular-safety readiness (especially for OLIF51), and clinical capability. Do not assume prior inpatient defaults still apply - re-verify per patient, per payer, per date of service, and confirm 22558's final Addendum AA/B status.

13

Policy, Evidence & Source Guidance

Commercial Payer Comparison

Commercial and Medicare Advantage plans almost universally require prior authorization for lumbar fusion and most delegate the clinical review to a specialty utilization-management vendor. Criteria are broadly similar in structure instability or listhesis, concordant imaging, failed conservative care, risk-factor documentation - but differ in thresholds. Synthesized, not reproduced:

Reviewer / policy	Emphasis & notable elements (verify current version)
eviCore (CMM-609 Lumbar Fusion)	One guideline covers anterior, oblique, lateral, posterior, and combined approaches; criteria keyed to spondylolisthesis grade (Meyerding), anterolisthesis on imaging, documented instability, and failed conservative care; nicotine-free status documentation is a recurring requirement.
Carelon (Spine Surgery)	Degenerative spondylolisthesis with a fixed anterolisthesis or dynamic movement (on the order of 3 mm) on flexion/extension films plus symptoms/impairment not responding to at least ~6 weeks of conservative care; osteopenia/osteoporosis (DEXA T-score at or below -1.0) and implant-material allergy are cautionary/exclusionary.
Cohere Health	Digital intake with real-time criteria; instability, imaging correlation, and conservative-care history mirror the common framework; completeness at intake drives auto-approval.
Evolent / TurningPoint	MSK surgical UM programs applying comparable instability-plus-conservative-care logic; used by select regional and Medicaid plans.
UnitedHealthcare	Commercial spine PA plus a Medicare Advantage spine-procedures policy; documented instability/listhesis and neural-compression correlation required; IONM has its own policy.
Aetna (CPB 0743 / 0016)	CPB 0743 supplements LCD L37848 and requires radiologic evidence of neural compression; interbody-device policy (CPB 0016) ties cage coverage to meeting the fusion criteria; fusion for DDD listed as not medically necessary.
Cigna (via eviCore) / Humana / BCBS	Cigna applies eviCore CMM-609; Humana and BCBS plans (e.g., Premera 7.01.542) track the common instability-plus-failed-care framework.

Common threads and an OLIF-specific note. Across payers: instability, listhesis, or a defined reconstructive/deformity goal - not stenosis or axial pain alone - is the fusion pivot; dynamic imaging is expected when instability is claimed; a dated, structured conservative-care history is mandatory. For OLIF, also expect scrutiny of the indirect-decompression rationale when no direct decompression is coded, and treat any neuromonitoring, when used, as a separately governed service. Always confirm which vendor holds the delegation for the specific plan and product before submitting.

14

Coverage, Documentation & Operations

Prior Authorization Workflow

A repeatable, front-loaded workflow is the difference between a first-pass approval and a cycle of information requests and peer-to-peer reviews. A representative end-to-end path:

n

1. Verify benefits & delegation. Confirm the plan/product, that fusion requires PA (it almost always does), which

UM vendor holds the review, and whether neuromonitoring (if used) requires separate authorization.

n

1. Assemble the packet. Surgeon note with the structural diagnosis and levels, correlated MRI/CT with pre-psoas

corridor/vascular assessment, flexion/extension and (for deformity) coronal films, the itemized conservative-care ledger, the indirect-decompression rationale, and the medical-necessity statement. n

1. Map to the criteria. Walk the record against the specific vendor's criteria and fill gaps before submitting, including

corridor feasibility (and OLIF51 venous anatomy). n

1. Resolve approach coding. Where OLIF51 involves an access surgeon, confirm the co-surgeon arrangement;

confirm any neuromonitoring reporting professional. n

1. Submit & document. Submit through the required channel; record the authorization/reference number, the

criteria version, and the reviewer. n

1. Manage clinical review / peer-to-peer. Prepare the surgeon with the instability or deformity narrative, the

indirect-decompression rationale, and the conservative-care timeline. n

1. Confirm site of service & codes. Ensure the authorized CPT® set matches the plan (primary, add-on levels,

anterior/oblique plate vs. posterior instrumentation, interbody device, graft) and that the site supports the approach. n

1. Schedule, re-verify & close the loop to billing. Confirm the authorization is active for the scheduled date; hand

off the authorization, approved codes, co-surgeon/IONM details, and site to revenue cycle so the claim matches exactly.

15

Coverage, Documentation & Operations

Common Prior Authorization Denials

The recurring denial patterns for OLIF are predictable and therefore preventable:

n Insufficient conservative care. Duration not met (note the common six-month oblique-device threshold), or the trial is described but not dated/itemized. n No documented instability or reconstructive goal. Fusion requested for axial pain or DDD without listhesis, dynamic imaging, or a defined coronal/deformity objective. n Missing dynamic or alignment imaging. Instability or deformity claimed without the supporting films. n Unjustified indirect decompression. Neural compression not shown to be addressable by disc-height restoration, with no direct decompression planned. n Corridor / level concerns. Unfavorable pre-psoas or L5-S1 venous anatomy, or an upper-lumbar target without a plan for the anatomical constraints. n Non-covered indication / technique. Isolated discogenic pain; investigational device or technique. n Approach-coding mismatch. OLIF51 access-surgeon or co-surgeon arrangement not reflected; OLIF miscoded as (or confused with) a posterior technique. n Site-of-service denial. Inpatient requested without 2-midnight support, or a setting the plan does not authorize for the code.

16

Coverage, Documentation & Operations

Appeal Strategies

Effective appeals answer the specific denial rationale with specific, dated documentation - they do not restate the original request. Practical approach:

n Read the denial reason literally and rebut that exact point (e.g., dynamic instability measurements; coronal deformity parameters; the indirect-decompression mechanism). n Supply the dated conservative-care ledger if the denial cites insufficient non-operative care. n Add the surgeon's correlation letter tying imaging to symptoms and exam and explaining the oblique approach and how decompression is achieved. n Address approach coding directly where the denial concerns the OLIF51 access-surgeon arrangement or an approach mismatch. n Cite the applicable policy back to the payer and prepare a concise, two-minute peer-to-peer summary.

n Escalate methodically through reconsideration and external / independent review, tracking timely-filing deadlines.

GOHEALTHCARE BEST PRACTICES - PREVENT THE PEER-TO-PEER

The most efficient appeal is the one never needed. Route every fusion request through a single pre-submission checklist mapped to the specific vendor's criteria - instability or reconstructive goal documented, dynamic/coronal imaging attached, corridor feasibility confirmed, indirect-decompression rationale stated, OLIF51 access-surgeon arrangement clarified, conservative care itemized, and a surgeon medical-necessity statement included. This converts the majority of would-be peer-to-peer reviews into first-pass approvals.

17

Coding, Billing & Revenue Integrity

Coding & Billing Overview

This is an operational coding orientation, not a reimbursement or NCCI-edit manual; detailed payment methodology belongs to the GoHealthcare Revenue Cycle Knowledge Center. Key principles for OLIF:

n OLIF/ATP is reported with the anterior/anterolateral interbody arthrodesis code 22558 (single interspace, lumbar) there is no distinct oblique code; +22585 is added for each additional interspace. n OLIF is not OLLIF. The anterolateral, retroperitoneal oblique technique (OLIF/ATP) is reported with 22558; a posterior trans-Kambin "OLLIF" is a different procedure for which 22558 is not appropriate. Confirm the operative approach before assigning 22558. n The minimal discectomy intrinsic to interspace preparation is included in the arthrodesis and is not separately reported. n The interbody device (+22853) and bone graft are reported with their own add-on codes. n An anterior/oblique plate is reported with the anterior instrumentation codes (22845 for 2-3 vertebral segments, 22846 for 4-7, 22847 for 8+). When OLIF is supplemented with posterior pedicle-screw fixation, the posterior instrumentation codes (e.g., 22840 non-segmental, 22842 segmental) apply per the operative note. n Co-surgeon modifier 62 may apply when an access/exposure surgeon and the spine surgeon each perform a distinct part - a scenario most common at L5-S1 (OLIF51), which is ALIF-like. n Neuromonitoring , when a dedicated professional performs it, is reported with +95940 / +95941 (Medicare G0453); it is bundled if the operating surgeon performs it. It is used more selectively in OLIF than in transpsoas cases. n The same 22558 code also reports ALIF and XLIF; the specific corridor is documented in the operative note, not distinguished by a different arthrodesis code.

18

Coding, Billing & Revenue Integrity

Applicable CPT Codes

Code	Descriptor (abbreviated)	Role in OLIF/ATP
22558	Arthrodesis, anterior interbody technique, incl. minimal discectomy to prepare interspace (other than for decompression); lumbar	Primary code (also ALIF/XLIF)
+22585	Each additional interspace; lumbar	Add-on for each additional level
+22853	Insertion of interbody biomechanical device (e.g., cage/mesh) in conjunction with interbody arthrodesis, each interspace	Oblique interbody spacer add-on
+22845 / +22846 / +22847	Anterior instrumentation; 2-3 / 4-7 / 8+ vertebral segments	Anterior/oblique plate add-on
+22840 / +22842	Posterior non-segmental / segmental (3-6 segments) instrumentation	When supplemented with posterior fixation
+95940 / +95941 (G0453)	Continuous IONM, in-OR one-on-one (15 min) / remote (per hour; Medicare G0453)	Neuromonitoring, when used (dedicated professional only)

Code	Descriptor (abbreviated)	Role in OLIF/ATP
+20936 / +20937 / +20938 / 20930 / 20931	Autograft (local / separate incision / structural) / allograft (morselized / structural)	Bone graft add-on codes

Codes are listed for operational orientation and must be verified against the current CPT® code set, payer policy, and NCCI edits before submission. Add-on codes are reported in addition to the primary procedure and are exempt from modifier 51. Confirm the operative approach is truly anterolateral/oblique (not posterior) before assigning 22558.

19

Coverage, Documentation & Operations

HCPCS Codes (When Applicable)

For most physician (professional) claims, the fusion is captured by the CPT® set above. Where neuromonitoring is used, G0453 is the Medicare reader code used in place of +95941 for remote/nearby monitoring. On the facility side (hospital outpatient / ASC), HCPCS Level II codes may appear for device and biologic reporting, and pass-through or device-category C-codes may apply to specific oblique implants in the OPPS/ASC setting. Because device and IONM coding are setting- and date-specific, confirm the current facility HCPCS/C-code, any applicable IONM reader code, and any device-intensive designation with the facility's chargemaster and the payer at the date of service.

20

Coding, Billing & Revenue Integrity

Common ICD-10-CM Diagnosis Codes

Diagnosis selection must be specific to region and to the documented clinical detail. The codes below are frequently applicable to OLIF indications and were confirmed as billable for the current fiscal year (valid through 09/30/2026); always code to the documentation.

ICD-10-CM	Description	Note
M43.16	Spondylolisthesis, lumbar region	Billable
M43.17	Spondylolisthesis, lumbosacral region	Billable (relevant to OLIF51 at L5-S1)
M48.061	Spinal stenosis, lumbar region, without neurogenic claudication	Billable; parent M48.06 is NOT billable
M48.062	Spinal stenosis, lumbar region, with neurogenic claudication	Requires documented claudication, not imaging alone
M51.16	Intervertebral disc disorder with radiculopathy, lumbar region	Billable
M51.26	Other intervertebral disc displacement, lumbar region	Herniation without myelopathy/radiculopathy
M51.36	Other intervertebral disc degeneration, lumbar region	DDD alone rarely supports fusion
M41.86 / M41.26	Other forms of scoliosis / other idiopathic scoliosis, lumbar region	Degenerative / adult scoliosis (deformity context) - code to type & site
M53.2X6 / M53.2X7	Spinal instabilities, lumbar / lumbosacral region	Code to the documented site of instability
M96.0	Pseudarthrosis after arthrodesis or fusion	Failed prior fusion (revision context)

Avoid non-billable parent codes (for example, M48.06 for lumbar stenosis requires the 5th/6th-character specificity of M48.061 or M48.062). Match the region to the operative level; L5-S1 (OLIF51) frequently uses the lumbosacral-region codes.

21

Coding, Billing & Revenue Integrity

Applicable Modifiers

Modifier	Use in the OLIF/ATP context
-62	Two surgeons (co-surgeons) - most relevant at L5-S1 (OLIF51), where an access/exposure surgeon and the spine surgeon each perform a distinct part and each dictates an operative note; may apply to 22558 and +22585.
-51	Multiple procedures (add-on codes, including instrumentation and IONM, are exempt from -51).
-59 / X{EPSU}	Distinct procedural service - e.g., a separately reportable service at a different level; use the most specific X modifier where required.
-22	Increased procedural services - only with explicit documentation of substantially greater work; typically applied to the primary code.
-80 / -82	Assistant surgeon / assistant when a qualified resident is unavailable, per payer rules.
TC / 26	Do not apply to the IONM codes +95940 / +95941 / G0453.
-58 / -78 / -79	Staged/related/unrelated procedure during the global period (e.g., staged posterior fixation, or revisions).

22

Coverage, Documentation & Operations

Clinical Documentation Checklist

A consolidated, pre-submission checklist for the authorization packet and the operative-note handoff to coding:

n Structural diagnosis with level(s); for listhesis, grade; for deformity, coronal/sagittal parameters n Concordant symptom description with duration and neurological examination findings n MRI/CT correlated to the symptomatic level, plus axial pre-psoas corridor / vascular assessment n For L5-S1 (OLIF51), iliac/iliolumbar venous anatomy and corridor feasibility documented n Weight-bearing flexion/extension radiographs for instability; coronal/alignment films for deformity n Itemized, dated conservative-care ledger (commonly six months) n Explicit indirect-decompression rationale, or a documented direct-decompression plan n Access-surgeon / co-surgeon arrangement documented where OLIF51 is planned n Nicotine status + cessation counseling; bone-density status (subsidence risk) n Confirmation the operative approach is anterolateral/oblique (not posterior) before 22558 is assigned n Planned levels; standalone vs. plate vs. posterior supplementation; interbody device; graft/biologic n Explicit surgeon medical-necessity statement, site-of-service rationale, and authorization on file

23

Coverage, Documentation & Operations

Procedure Comparison (When Applicable)

OLIF is one of several interbody approaches. The comparison below is operational, not a surgical selection guide; approach choice is the surgeon's clinical decision.

Approach	Corridor / access	Operational notes
OLIF / ATP	Anterolateral oblique, pre-psoas (between psoas & vessels)	Code 22558; L1/L2-L5 (OLIF25) and L5-S1 (OLIF51); less plexus risk, more vascular/sympathetic/ureteral risk; selective neuromonitoring; off-label rhBMP-2
XLIF / LLIF	Lateral, transpsoas	Also 22558; T12/L1-L4/5 (not L5-S1); mandatory neuromonitoring; lumbar-plexus risk
ALIF	Anterior retroperitoneal	Also 22558; best L5-S1 access; access surgeon; on-label rhBMP-2 (single level)

Approach	Corridor / access	Operational notes
TLIF	Posterior, transforaminal	Combined code 22633; direct decompression; posterior rhBMP-2 off-label
PLIF	Posterior, bilateral to disc	Straight interbody = 22630
Decompression alone	Posterior, no fusion	Preferred when no instability; the payer-favored alternative in select degenerative spondylolisthesis

ALIF, XLIF, TLIF, PLIF, and revision lumbar fusion are addressed in their own guides in the GoHealthcare MSK Specialty Procedure Library™.

24

GoHealthcare Operational Guidance

GoHealthcare Clinical Insights

Confirm the corridor, not just the diagnosis. OLIF feasibility depends on the pre-psoas window and, at L5-S1, the venous anatomy - document the axial assessment.

Treat OLIF51 like an ALIF. Plan the access-surgeon arrangement, co-surgeon coding, and consent (vascular, retrograde ejaculation) for the L5-S1 portion specifically.

State the indirect-decompression mechanism. When no direct decompression is coded, explain how disc-height restoration decompresses the symptomatic level, supported by imaging.

Do not confuse OLIF with OLLIF. Confirm the approach is anterolateral/retroperitoneal before assigning 22558; a posterior trans-Kambin technique is coded differently.

25

GoHealthcare Operational Guidance

GoHealthcare Leadership Perspective

OLIF is best understood as a corridor innovation layered onto the same fusion economics and coverage logic as the other interbody approaches. Its appeal - reduced psoas/plexus morbidity, powerful alignment correction, and true L1-to-sacrum access in a single position - comes with a distinctive vascular, sympathetic, and ureteral risk profile and, at L5-S1, an ALIF-like access-surgeon dimension. The 2026 elimination of the Inpatient-Only list for musculoskeletal procedures adds a site-of-service decision that is genuinely consequential for an approach whose safety depends on vascular readiness.

The durable advantage is a criteria-mapped intake that captures OLIF's specifics alongside the universal fusion requirements: instability or deformity documented, corridor feasibility confirmed, the indirect-decompression rationale stated, the OLIF51 access-surgeon arrangement clarified, and the approach correctly identified as oblique rather than posterior. The same discipline that prevents denials protects the organization on compliance and supports clean, auditable revenue. AI-enabled intake and criteria-matching tools accelerate this but amplify a sound process rather than replace the clinical judgment that anchors medical necessity.

26

GoHealthcare Operational Guidance

GoHealthcare Prior Authorization Insight

Flag the L5-S1 arrangement early. If OLIF51 is planned, confirm the access-surgeon / co-surgeon setup and consent before submission so authorization, operative note, and claim agree.

Document corridor feasibility. A pended OLIF is often one where the pre-psoas or L5-S1 venous corridor was never addressed in the record; include the axial assessment.

Quantify everything. "Chronic pain, failed conservative treatment" is not reviewable. "6 months of PT, two injections with dated partial relief, ODI 45, grade 1 anterolisthesis with 4 mm translation at L4-5, planned indirect decompression" is.

Get the approach label right. Ensure the record and the code agree that this is an anterolateral/oblique fusion (22558), not a posterior technique - approach-coding mismatches drive avoidable denials and audits.

27

GoHealthcare Operational Guidance

GoHealthcare Case Study

Clinical scenario. A patient in the sixth decade presents with mechanical back pain, bilateral leg pain, and a degenerative lumbar curve, with instability and foraminal narrowing at L3-4 and L4-5 and a collapsed, symptomatic L5-S1.

Documentation challenges. The initial authorization packet led with pain severity, attached only supine MRI, described conservative care as "PT and injections" without dates, did not address the pre-psoas corridor or the L5-S1 venous anatomy, and did not indicate that an access surgeon would assist at L5-S1.

Prior authorization barriers. The delegated vendor pended the request citing (1) no dynamic imaging, (2) an unquantified conservative-care history, (3) no decompression rationale, and (4) an unclear approach at L5-S1; the co-surgeon arrangement was also unaddressed.

Payer considerations. The plan's criteria required instability on weight-bearing films or a defined deformity objective, a documented failed conservative-care course, and - because decompression was indirect - a clear mechanism; the L5-S1 exposure was ALIF-like and implicated co-surgeon rules.

Operational workflow. The authorization lead obtained standing flexion/extension and coronal films (documenting translation and a Cobb angle), reconstructed a six-month conservative-care ledger, added a surgeon letter explaining OLIF25 at L3-4/L4-5 with coronal correction and indirect decompression plus OLIF51 at L5-S1 for anterior-column support, documented the pre-psoas and L5-S1 venous corridor assessment, and confirmed an access surgeon for the L5-S1 portion.

Resolution strategy. The rebuilt packet was resubmitted mapped line-by-line to the vendor's criteria, with the surgeon briefed for a two-minute peer-to-peer focused on instability, deformity, and the indirect-decompression mechanism, and the co-surgeon arrangement flagged for correct reporting.

Outcome. The request was approved without a formal denial; the scheduled CPT® set (22558 with +22585 for the added levels, +22853 per level, posterior supplemental instrumentation, graft, and a co-surgeon arrangement at L5-S1) and site of service matched the authorization, and the claims adjudicated cleanly.

Lessons learned. The case turned on OLIF-specific corrections: documenting corridor feasibility, stating the indirect-decompression mechanism, and planning the L5-S1 (OLIF51) portion as an ALIF-like, access-surgeon-assisted exposure with the right co-surgeon coding.

28

GoHealthcare Operational Guidance

GoHealthcare Best Practices

n Adopt a single pre-submission fusion checklist mapped to each major vendor's criteria; make it mandatory intake. n Document pre-psoas corridor feasibility and, for L5-S1, the venous anatomy for OLIF51. n Plan the OLIF51 access-surgeon / co-surgeon arrangement and consent before the case. n State the indirect-decompression mechanism whenever no direct decompression is coded. n Confirm the approach is anterolateral/oblique (not posterior) before assigning 22558. n Align the conservative-care ledger with the six-month oblique-device / payer threshold. n Run a two-role QA (coder + clinical reviewer) before submission and again before the claim drops. n Re-verify site-of-service eligibility (22558 Addendum AA/B) per patient/payer/date.

29

Coverage, Documentation & Operations

Common Mistakes

n Confusing OLIF (anterolateral, retroperitoneal, 22558) with OLLIF (posterior trans-Kambin), leading to an approach-coding mismatch. n Omitting or mis-applying the co-surgeon modifier 62 when an access surgeon assisted at L5-S1 (OLIF51). n Reporting an anterior/oblique plate with posterior instrumentation codes, or vice versa. n Failing to document the indirect-decompression mechanism when no decompression is coded. n Submitting instability requests with supine imaging only; omitting coronal films for deformity. n Not documenting pre-psoas or L5-S1 venous corridor feasibility. n Assuming rhBMP-2 is on-label for oblique fusion (it is on-label only for single-level anterior ALIF). n Using non-billable parent ICD-10 codes (e.g., M48.06) or imprecise scoliosis codes.

30

GoHealthcare Operational Guidance

Pearls and Pitfalls

Pearls

n OLIF stays anterior to the psoas - lower plexus/psoas morbidity than transpsoas, at the cost of vascular proximity. n OLIF can reach L5-S1 (OLIF51), enabling an L1-to-sacrum construct, often in a single position. n Left-sided approach keeps the aorta (not the fragile vena cava) in view. n Neuromonitoring is selective in OLIF; when a dedicated professional is used, it is a separate service.

Pitfalls

n Sympathetic-chain injury (warmer/discolored leg), ureteral injury, and vascular injury are the signature OLIF risks counsel and document. n OLIF51 vascular risk is higher; treat it as an ALIF-like exposure. n Subsidence risk rises with osteopenia and over-distraction; plan fixation accordingly. n Indirect decompression is insufficient for high-grade central stenosis or sequestered fragments.

31

Coverage, Documentation & Operations

Frequently Asked Questions

What is the primary CPT® code for OLIF/ATP?

22558 (anterior/anterolateral interbody arthrodesis, single lumbar interspace); +22585 for each additional interspace. There is no distinct oblique arthrodesis code.

Is OLIF the same as OLLIF?

No. OLIF/ATP is an anterolateral, retroperitoneal oblique approach reported with 22558. OLLIF is a different posterior trans-Kambin technique for which 22558 is not appropriate. Confirm the operative approach before coding.

Is OLIF coded the same as ALIF and XLIF?

Yes - all three use 22558. The specific corridor (anterior, oblique pre-psoas, or lateral transpsoas) is documented in the operative note, not distinguished by a different arthrodesis code.

Can OLIF reach L5-S1?

Yes, through the OLIF51 variant, which works below the vascular bifurcation much like an anterior lumbar interbody fusion. This is a key difference from the transpsoas (XLIF) approach, which generally cannot reach L5-S1.

What is the difference between OLIF25 and OLIF51?

OLIF25 denotes the L1/L2-L5 oblique approach above the vascular bifurcation; OLIF51 denotes the L5-S1 approach below the bifurcation. OLIF51 is ALIF-like and often uses an access surgeon.

Why is OLIF performed from the left side?

The left-sided approach keeps the thick-walled aorta (rather than the thin-walled vena cava) in the working field and allows the peritoneal contents to fall away with gravity in the lateral decubitus position.

Does OLIF require neuromonitoring like XLIF?

Less so. Because OLIF stays anterior to the psoas and does not traverse the lumbar plexus, neuromonitoring is used more selectively. When a dedicated monitoring professional performs it, it is reported with +95940 / +95941 (Medicare G0453); if the surgeon performs it, it is bundled.

How is the interbody cage coded?

With the interbody biomechanical device add-on +22853 (device inserted in conjunction with interbody arthrodesis), reported per interspace.

How is an anterior/oblique plate coded versus posterior screws?

An anterior/oblique plate uses the anterior instrumentation codes (22845 for 2-3 vertebral segments, 22846 for 4-7, 22847 for 8+). Supplemental posterior pedicle-screw fixation uses the posterior instrumentation codes (e.g., 22840, 22842).

When does the co-surgeon modifier 62 apply to OLIF?

Most often at L5-S1 (OLIF51), where an access/exposure surgeon and the spine surgeon each perform a distinct part and each dictates an operative note; modifier 62 may then apply to 22558 and +22585.

What are the signature OLIF complications?

Sympathetic-chain injury (a warmer, sometimes discolored ipsilateral leg), ureteral injury, and vascular injury - with reduced lumbar-plexus and psoas morbidity relative to the transpsoas approach; retrograde ejaculation is a risk at L5-S1.

Does Medicare have an NCD for lumbar fusion?

No. Coverage is governed by MAC LCDs/articles, the OPPS/ASC framework, the Inpatient-Only transition, and the 2-midnight rule. Neuromonitoring, when used, has its own coverage articles.

Did OLIF move off the Medicare Inpatient-Only list for 2026?

OLIF is reported with 22558, which was among the fusion codes CMS identified in the CY2026 musculoskeletal-first IPO phase-out for removal and ASC-CPL addition. Published summaries most often cite the posterior codes (22630/22633); confirm 22558's final OPPS Addendum B / ASC Addendum AA status at the date of service.

Which utilization-management vendors review lumbar fusion?

Commonly eviCore (CMM-609), Carelon, Cohere, Evolent, and TurningPoint, depending on the plan and product. Confirm the delegation before submitting.

How much conservative care is required before approval?

It varies - often a minimum of 6 weeks to 6 months. Oblique-device FDA labeling commonly references at least six months of non-operative treatment, so aligning to six months satisfies both the payer and the device label.

What imaging do payers expect?

MRI or CT establishing the pathology (with axial pre-psoas corridor / vascular assessment), weight-bearing flexion/extension films for instability, and coronal/alignment films when deformity correction is a goal.

Is fusion for degenerative disc disease covered?

Isolated degenerative disc disease / discogenic axial pain without instability or a defined reconstructive goal is the classic payer-scrutinized indication across CMS-aligned LCDs and most commercial policies.

Is rhBMP-2 (Infuse) on-label for OLIF?

No. Its FDA approval is limited to single-level anterior ALIF with a specified cage; oblique (OLIF/ATP) use is off-label and payer-restricted - document rationale and consent if used.

What are the most common denial reasons?

Insufficient/undated conservative care, no documented instability or deformity goal, missing dynamic/coronal imaging, an unjustified indirect-decompression rationale, unaddressed corridor feasibility, an OLIF51 access-surgeon/co-surgeon mismatch, and OLIF/OLLIF approach confusion.

How do I prevent a peer-to-peer review?

Front-load the packet against the vendor's criteria: instability or deformity documented, corridor feasibility confirmed, indirect-decompression rationale stated, OLIF51 access-surgeon arrangement clarified, conservative care itemized, and a surgeon medical-necessity statement included.

How should site of service be documented in 2026?

State the clinical rationale for inpatient, HOPD, or ASC based on comorbidities, expected recovery, and safety (including vascular readiness for OLIF51), and confirm the authorized site matches the claim; re-verify per payer and date of service.

32

Coverage, Documentation & Operations

Key Takeaways

n OLIF/ATP is reported with 22558 (+22585 per additional level) - the same code as ALIF and XLIF; there is no distinct oblique arthrodesis code. n OLIF is not OLLIF: confirm the approach is anterolateral/retroperitoneal (22558), not a posterior trans-Kambin technique. n OLIF works in the pre-psoas corridor between the psoas and the great vessels - less plexus/psoas morbidity than transpsoas, more vascular/sympathetic/ureteral risk. n OLIF can reach L5-S1 (OLIF51), which is ALIF-like, works below the bifurcation, and often uses an access surgeon (co-surgeon modifier 62). n Neuromonitoring is selective in OLIF; when a dedicated professional performs it, +95940 / +95941 (G0453) apply and are bundled if the surgeon monitors. n Document the indirect-decompression mechanism whenever no direct decompression is coded. n rhBMP-2 is off-label for OLIF (on-label only for single-level anterior ALIF). For CY2026, 22558 was among the codes CMS identified for IPO removal / ASC-CPL addition - confirm final Addendum AA/B status.

33

Coverage, Documentation & Operations

Future Outlook

Several trends will shape OLIF operations over the coming cycles:

n Single-position surgery. Lateral single-position OLIF that permits same-position posterior fixation continues to expand, with implications for operative time, workflow, and how combined constructs are documented and coded. n L5-S1 (OLIF51) refinement. Improved retractors and navigation are making the L5-S1 oblique approach more reproducible, sharpening the ALIF-versus-OLIF51 decision and its access-surgeon and coding implications. n Expandable and porous implants. Expandable oblique cages and porous titanium continue to develop to reduce subsidence and improve alignment, with device-intensive economics following. n Site-of-service migration. With the IPO list phasing out and 22558 moving toward ASC eligibility, selected oblique fusions may shift toward outpatient/ASC settings - contingent on vascular-safety readiness and device-intensive payment modeling. n AI-enabled authorization. Payer-side automated review and provider-side criteria-matching tools will accelerate adjudication; the advantage accrues to practices whose documentation is already complete and criteria-mapped.

34

Policy, Evidence & Source Guidance

References

Authoritative sources; verify the current version and effective date of each before relying on it. URLs were active at the time of authorship.

1. Centers for Medicare & Medicaid Services. Medicare Coverage Database (NCDs, LCDs, Articles), including IONM billing/coding

article A56722. https://www.cms.gov/medicare-coverage-database

1. CMS. CY2026 Hospital OPPS and Ambulatory Surgical Center Payment System Final Rule (Inpatient-Only list phase-out; ASC

Covered Procedures List, Addendum AA). https://www.cms.gov/medicare/payment/prospective-payment-systems/hospital-outpatient

1. LCD L37848, Lumbar Spinal Fusion (representative MAC LCD).

https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=37848

1. eviCore by Evernorth. CMM-609: Lumbar Fusion (Arthrodesis) clinical guidelines.

https://www.evicore.com/provider/clinical-guidelines

1. Carelon Medical Benefits Management. Spine Surgery Clinical Appropriateness Guidelines.

https://guidelines.carelonmedicalbenefitsmanagement.com

1. Aetna. Clinical Policy Bulletin 0743, Spinal Surgery: Laminectomy and Fusion; CPB 0016, Interbody Fusion Devices.

https://www.aetna.com/cpb/medical/data/700_799/0743.html

1. North American Spine Society (NASS). Coverage Policy Recommendations - Lumbar Fusion; coding guidance for interbody fusion

(including anterolateral/oblique approaches). https://www.spine.org

1. Mayer HM. A new microsurgical technique for minimally invasive anterior lumbar interbody fusion. Spine (Phila Pa 1976).

1997;22(6):691-699. https://journals.lww.com/spinejournal

1. Silvestre C, Mac-Thiong JM, Hilmi R, Roussouly P. Complications and morbidities of mini-open anterior retroperitoneal lumbar

interbody fusion: oblique lumbar interbody fusion in 179 patients. Asian Spine J. 2012;6(2):89-97. https://www.asianspinejournal.org

1. Woods KRM, Billys JB, Hynes RA. Technical description of oblique lateral interbody fusion at L1-L5 (OLIF25) and at L5-S1 (OLIF51)

and evaluation of complication and fusion rates. Spine J. 2017;17(4):545-553. https://www.thespinejournalonline.com

1. Ghogawala Z, et al. Laminectomy plus fusion versus laminectomy alone for lumbar spondylolisthesis (SLIP). N Engl J Med.

2016;374(15):1424-1434. https://www.nejm.org

1. Forsth P, et al. A randomized, controlled trial of fusion surgery for lumbar spinal stenosis. N Engl J Med. 2016;374(15):1413-1423.

https://www.nejm.org

1. Austevoll IM, et al. Decompression with or without fusion in degenerative lumbar spondylolisthesis (NORDSTEN-DS). N Engl J Med.

2021;385(6):526-538. https://www.nejm.org

1. U.S. Food & Drug Administration. Intervertebral body fusion device clearances (anterior/oblique lumbar systems) and rhBMP-2

(Infuse) labeling. https://www.fda.gov

1. American Medical Association. CPT® code set (current year), including Intraoperative Neurophysiology codes 95940-95941.

https://www.ama-assn.org/practice-management/cpt

Build a Defensible, Scalable Procedure Workflow

GoHealthcare supports prior authorization, medical-necessity documentation, payer policy interpretation, coding and revenue integrity, appeals, and MSK specialty workflow design.

Request HelpReview the Case Study Library

Developed By

Pinky Maniri

MSc, BSc, CRCR, CSAPM, CSPPM, CSBI, CSPR, CSAF, Certified in Healthcare A.I. Governance

Founder and Chief Executive Officer, GoHealthcare Practice Solutions

View LinkedIn

Educational and Operational Disclaimer

This content is provided for educational and operational planning purposes and is not medical, legal, coding, reimbursement, or payer-contract advice. Coverage, authorization, coding, payment, and clinical requirements vary by patient, plan, product, jurisdiction, Medicare Administrative Contractor, date of service, setting, and current policy. Verify the controlling source before scheduling, authorization, billing, appeal, or clinical decision-making. Authorization does not guarantee coverage or payment.